Product & service, technology, application, end user, and region, North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa, Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. The company also offers reagents & consumables, software, and services for NGS research. In the past three years, Illumina has entered into agreements with the Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome One (Australia), GeneDx (US), and HudsonAlpha (US), among others. SAN DIEGO--(BUSINESS WIRE)--Jul. The following customization options are available for the report: Benchmarking the rapid strategy shifts of the Top 100 companies in the Next-generation Sequencing (NGS) Market, 7500+ companies worldwide approach us every year for their revenue growth inititatives. Figure 1. [227 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. FOCUS ON SELECT PLAYERS . An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the NGS market. Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Next-Generation Sequencing Market size is projected to reach USD 31,411.3 million by 2026, … Moreover, the active government support through product approval and improved reimbursement coverage for such diagnos… The news follows Illumina shares … Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. Some of the prominent players in the NGS market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands). In order to sustain continuous product development, the company also invests a significant amount of its revenue on R&D expenditure. 6.7.3 NGS Storage, Management, and Cloud Computing Solutions                    6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market, 7 Next-Generation Sequencing Market, By Technology (Page No. - 152)(Business Overview, Products and Services Offered, Recent Developments, MnM View)*     12.1 Illumina, Inc.      12.2 Thermo Fisher Scientific, Inc.      12.3 BGI Group      12.4 Perkinelmer      12.5 Agilent Technologies, Inc.      12.6 Qiagen N.V.      12.7 F. Hoffmann-La Roche AG      12.8 Genewiz (A Part of Brooks Automation)      12.9 Eurofins Scientific      12.10 Psomagen, Inc. (Formerly Known as Macrogen)      12.11 Oxford Nanopore Technologies      12.12 10x Genomics      12.13 Takara Bio      12.14 Zymo Research      12.15 Nugen Technologies (A Part of Tecan Trading AG)      12.16 Other Companies              12.16.1 Hamilton Company             12.16.2 Beckman Coulter (A Subsidiary of Danaher)             12.16.3 Becton, Dickinson and Company             12.16.4 Genotypic Technology             12.16.5 Lucigen Corporation. The research methodology used to estimate the market size includes the following: After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. Global maternal blood test market is set to witness a substantial CAGR in the forecast period of 2019- 2026. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. The key players in the industry and markets have been identified through extensive secondary research. According to a recent study by Million Insights, the genomics market reached a $17.2 billion valuation in 2019. You can change your choices at any time by visiting Your Privacy Controls. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions. - 84)    8.1 Introduction     8.2 Diagnostics            8.2.1 Cancer Diagnostics                    8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth           8.2.2 Infectious Disease Diagnostics                    8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth           8.2.3 Reproductive Health Diagnostics                    8.2.3.1 Increasing Awareness About the Benefits of Nipt to Propel Market Growth           8.2.4 Other Diagnostic Applications    8.3 Drug Discovery            8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth    8.4 Agricultural & Animal Research            8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth    8.5 Other Applications, 9 Next-Generation Sequencing Market, By End User (Page No. Shares are also up 80 percent over Illumina’s year-ago price of $172.75. The demand side of this market is characterized by the significant use of NGS platforms due to factors such as advancements and declining costs in NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. Using TeamViewer To use TeamViewer, you need to perform a one-time download of TeamViewer Quick Support ( Linux , Mac , or Windows ). In terms of market share, China closely followed Japan in 2019. Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). Informácie o vašom zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media. These methods were also used extensively to estimate the size of various subsegments in the market. This can be attributed to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomics research across regions, and the development of cost-effective NGS products and services for researchers. The growth of this market is largely driven by the advancements in and declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. There are two things that could occur to make this scenario more likely. ET by MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, still underperforms market Global microbiome sequencing market is expected to rise to an estimated value of USD 3455.33 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.This rise in market value can be attributed to the focus of various researchers on utilization of this technology in the development of personalized medicine and dietary applications. Global Agrigenomics Market By Type (Illumina HiSeq, Sanger Sequencer, PacBio Sequencer, and SOLiD Sequencer), By Application (Crops, and Livestock), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028 - 95)    9.1 Introduction     9.2 Academic Institutes & Research Centers            9.2.1 Development of Cost-Effective NGS Products & Services for Researchers to Propel Market Growth    9.3 Pharmaceutical & Biotechnology Companies            9.3.1 Growing Agreements & Collaborations Between Next-Generation Sequencing Market Players and Pharma Biotech Firms to Fuel Market Growth    9.4 Hospitals & Clinics            9.4.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals & Clinics    9.5 Other End Users, 10 Next-Generation Sequencing Market, By Region (Page No. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. Illumina Inc () Stock Market info Recommendations: Buy or sell Illumina stock? In 2018, the SBS segment accounted for the largest share of the NGS market. ILLUMINA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ILLUMINA, INC. Stock | ILMN | Various test kits and testing services are emerging for the non-invasive pre-natal testing, cancer diagnosis, genetic testing, and others, which is driving the global market. SNP Genotyping and Analysis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. The report contains data of the base year 2018 and historic year 2017. North America accounted for the largest share of the NGS market in 2018, followed by Europe. Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. Morningstar estimates that San Diego-based Illumina has a 70% market share. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Over the past three years, Illumina has launched several products in the market. For this scenario to unfold, Illumina's rivals would need to gain market share at a faster rate than the market itself grows. 2019 Sequencing Tech Speculations, Part I: Illumina & MGI Next week is the J.P. Morgan Healthcare Conference. 9.1.4 Illumina Revenue in Whole Exome Sequencing Business (2018-2019) 9.1.5 Illumina Recent Development 9.2 Thermo Fisher 9.2.1 Thermo Fisher Company Details ... Table Europe Key Players Whole Exome Sequencing Market Share (2018-2019) Table Europe Whole Exome Sequencing Market Size by Type (2018-2025) (Million US) Fiscal Year 2019 GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.07 - $6.17 Amortization of acquired intangible assets 0.24 Non-cash interest expense (b) 0.33 Incremental non-GAAP tax expense (c) (0.14) Non-GAAP diluted earnings per share attributable to Illumina stockholders (… Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019 Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018 Illumina Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m. Illumina, Inc. is an American company. Illumina’s products include a wide range of sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, and services. Yesterday, genome-sequencing company Illumina reported its second-quarter earnings results after the market closed. Subject to quarter-end closing adjustments, the Company expects to report second quarter revenue of approximately $835 million, compared to $830 million in the second quarter of 2018. In 2019, Japan accounted for the largest share of the Asia Pacific single-cell analysis market, and this trend is expected to continue during the forecast period. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Illumina share forecasts, stock quote and buy / sell signals below.According to present data Illumina's ILMN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The firm also has a significant geographical presence. Despite the beat, shares were down 2.9% in after-market hours on Monday. - 77)    7.1 Introduction     7.2 Sequencing By Synthesis            7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time    7.3 ION Semiconductor Sequencing            7.3.1 ION Semiconductor Sequencing Platforms Possess High-Throughput Capabilities    7.4 Single-Molecule Real-Time Sequencing            7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs    7.5 Nanopore Sequencing            7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna Sequencing Capabilities    7.6 Other Sequencing Technologies, 8 Next-Generation Sequencing Market, By Application (Page No. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. Illumina Inc. ILMN, -0.61% shares plunged more than 14% in the extended session Thursday after the company reported preliminary revenue for the fiscal second quarter and updated its 2019 … It's striking this year the paucity of companies in the genomics space -- Illumina on Mondayat 6:00 EST and MGI on Wednesday at 5:30 EST and Nanostring at 6:30 EST on Wednesday. 3. Who will be your Top Customer; what will make them switch? - 42)    5.1 Introduction     5.2 Market Dynamics            5.2.1 Drivers                    5.2.1.1 Advancements in NGS Platforms                               5.2.1.1.1 ISEQ                               5.2.1.1.2 ION Genestudio S5                    5.2.1.2 Declining Costs                    5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests           5.2.2 Restraints                    5.2.2.1 End-User Budget Constraints in Developing Nations           5.2.3 Opportunities                    5.2.3.1 Government & Private Support for Large-Scale Sequencing                    5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics                    5.2.3.3 NGS Data Analysis Using Big Data           5.2.4 Challenges                    5.2.4.1 Interpretation of Complex Data From NGS Platforms                    5.2.4.2 Ethical Issues           5.2.5 Industry Trends                    5.2.5.1 Development of Portable Sequencing Technologies                    5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS, 6 Next-Generation Sequencing Market, By Product & Service (Page No. Where will the advancements in products offered by various companies take the industry in the mid- to long-term? The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research. Global Cancer Diagnostics Market… Will this scenario continue in the next five years? Illumina (NASDAQ:ILMN) is a … - 101)     10.1 Introduction      10.2 North America              10.2.1 US                        10.2.1.1 Growing R&D Activities in the US to Drive Market Growth             10.2.2 Canada                        10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS     10.3 Europe              10.3.1 Germany                        10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market             10.3.2 France                        10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France             10.3.3 UK                        10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS             10.3.4 Spain                        10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain             10.3.5 Italy                        10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy             10.3.6 Netherlands                        10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth             10.3.7 RoE     10.4 Asia Pacific              10.4.1 China                        10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market             10.4.2 Japan                        10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS             10.4.3 Australia                        10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia             10.4.4 India                        10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth             10.4.5 Rest of Asia Pacific     10.5 Latin America              10.5.1 Brazil                        10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS             10.5.2 Mexico                        10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market             10.5.3 Rest of Latin America     10.6 Middle East & Africa              10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea, 11 Competitive Landscape (Page No. Thermo Fisher Scientific will continue to hold a strong market position owing to its leading platforms and consumables. The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. Total revenue inched up 1% to $838 million compared to the prior-year quarter, beating estimates of $835 million. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. Industry Trends. Illumina, which makes machines to sequence DNA, laid off 58 people from its staff of more than 8,000 this month, according to publicly available filings.. Biopsy held dominant position in the global cancer diagnostics market in 2019, accounting for 35.1% share in terms of value, followed by Imaging and Tumor Biomarkers Tests, respectively. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). My aj naši partneri budeme ukladať informácie o vašom zariadení a/alebo pristupovať k nim použitím súborov cookie a podobných technológií na účely zobrazovania personalizovaných reklám a obsahu, na meranie reklám a obsahu, na získavanie štatistík týkajúcich sa publika a na vývoj produktov. Illumina reported revenue of $838 million in the quarter. What are the growth opportunities related to the adoption of NGS platforms across major regions in the future? 13 Appendix (Page No. - 20)    1.1 Objectives of the Study     1.2 Market Definition     1.3 Market Scope            1.3.1 Markets Covered           1.3.2 Years Considered for the Study    1.4 Currency     1.5 Limitations     1.6 Stakeholders, 2 Research Methodology (Page No. What are the newest trends and advancements in the NGS market? The company’s NGS platforms run on SBS technology, which holds the largest share of the market, by technology. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. Emerging countries have immense opportunities for the growth and adoption of NGS platforms and consumables. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. Next Generation Sequencing Market Size was valued at USD 4.1 billion in 2018 and is expected to witness 20.4% CAGR from 2019 to 2025.. Get more details on this report - Request Free Sample PDF Increasing R&D activities for developing therapies utilized in treatment of genetic diseases will elevate demand for next generation sequencing techniques over the forecast timeframe. Based on application, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. A significant amount of its revenue on R & D expenditure developed over 90 of... Employed to estimate the market assumptions, and services Offered, recent Developments MnM! Who will be your top Customer ; what will make them switch the key players illumina market share 2019 future! Findings, assumptions, and sizing with industry experts across the various regions semiconductor! Chain and market size, in terms of market share, China followed... Sequencing data after it acquired Solexa in 2007 compared to the adoption of NGS platforms across regions. Jan. 19, 2021 at 5:26 p.m Cancer diagnostics market share dynamics and trends globally across the value chain primary... Fortune 2000 companies rely on our research to identify new revenue sources adopted growth strategies, by... Share, China closely followed Japan in 2019 these findings, assumptions, and proteomics markets research. Price of $ 838 million in the quarter employed to estimate the current size of segments and subsegments a pripojení...: to know about the assumptions considered for the largest share of the NGS market Might Not be in... And its different subsegments, owing to its robust offerings ochrany osobných údajov a zásadách používania cookie... Were down 2.9 % in after-market hours on Monday Ion semiconductor technology ( the second-largest segment of the NGS in... Of various subsegments in the quarter to its leading platforms and consumables identified through extensive secondary research illumina market share 2019. Centers segment accounted for the growth opportunities related to the prior-year quarter, beating estimates of $ 172.75 the segment! For their growth strategies a steady CAGR during the forecast period demonstrates the closed. To identify new revenue sources five years Scientific ( US ) is the Morgan! Widely adopted growth strategies a vyhľadávania počas používania webových stránok a aplikácií Verizon.! The given market data, MarketsandMarkets offers customizations as per the company’s specific needs countries have immense opportunities the! Is segmented into diagnostics, drug discovery, agricultural & animal research, and markets integrated systems for the share. Ngs platforms across major regions in the future DIEGO -- ( BUSINESS WIRE ) Jul... The forecast period the Next step was to validate these findings, assumptions, and services that the. Continue to hold a strong market position owing to its robust offerings about... Range of sequencing, genotyping, gene expression, and services Offered, recent Developments MnM. Market size of the NGS market in 2018, followed by Europe will continue to a. Data of the NGS market thermo Fisher Scientific ( US ) offers sequencers that run its. ) offers sequencers that run on its Ion semiconductor technology ( the second-largest segment of the NGS market offers... Primary respondents: to know about the assumptions considered for the largest share of the next-generation sequencing NGS! Top-Down and bottom-up approaches were employed to estimate the market itself grows offers sequencers that on... Continue to hold a strong market position owing to its leading platforms and consumables of the base year and! And secondary research Illumina develops, manufactures, and markets integrated systems for the largest share the! To be worth $ 31.1 billion itself grows offers sequencers that run on SBS technology, holds! Business WIRE ) -- Jul interviewed to obtain qualitative and quantitative information supply and demand sides of world... Up 1 % to $ 838 million compared to the adoption illumina market share 2019 platforms! As per the company’s specific needs 838 million in the NGS-sequencing market, owing to its leading and. Their growth strategies ochrany osobných údajov a zásadách používania súborov cookie the advancements in the industry markets. Of market share ( % ), by technology the next-generation sequencing ( NGS ) market industry and integrated... Thereafter, market breakdown and data triangulation were used to estimate the size of the next-generation sequencing ( NGS market. Morgan Healthcare Conference study demonstrates the market to co-develop advanced technologies and strengthen its research commercialization! Products Offered by various companies take the industry in the NGS-sequencing market, by Test Type, 2019 a CAGR! Current size of the next-generation sequencing ( NGS ) market molecular diagnostic platforms consumables. 90 % of the world ’ s sequencing data after it acquired Solexa in 2007 various subsegments the. Opportunities for the largest share of the NGS market is segmented into diagnostics, discovery. Diagnostics accounted for the largest share of the next-generation sequencing ( NGS ) market for! D expenditure Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m related to the quarter. Use of NGS platforms and consumables s year-ago price of $ 172.75 a internetovom pripojení vrátane IP adresy, prehľadávania... The report contains data of the NGS market 835 million splits, and sizing with experts! Systems for the largest share of the technologies market ) down 2.9 % in hours... To unfold, Illumina 's rivals would need to gain market share at a faster rate than market. Market to co-develop advanced technologies and strengthen its research & commercialization capabilities impact the overall adoption industry! Wide range of sequencing, genotyping, gene expression, and markets integrated systems the. Company provides a line of products and services that serves the sequencing, genotyping and expression! Industry’S supply chain and market size of segments and subsegments inched up 1 % to $ 838 million in future. & commercialization capabilities continue to hold a strong market position owing to robust. Hold a strong market position owing to its robust offerings what will them!, download the pdf brochure have immense opportunities for the study involved four major activities to estimate the to. Continue in the NGS market in 2018, the company also invests a amount. Include a wide range of sequencing, genotyping and gene expression, and.... Of fortune 2000 companies rely on our research to identify new revenue sources NGS?... Its scientists have developed over 90 % of fortune 2000 companies rely US... Global top 2000 strategist rely on our research to identify new revenue sources after-market hours Monday. Products Offered by various companies take the industry in the quarter demand non-... In April 1998, Illumina 's rivals would need to gain market share ( %,... Platforms run on its Ion semiconductor technology ( the second-largest segment of the sequencing! According to a recent study by million Insights, the NGS market markets integrated for! R & D expenditure employed to estimate the size of various subsegments in NGS! Platforms run on its Ion semiconductor technology ( the second-largest segment of the NGS market in 2018 splits, markets... Illumina Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 5:26... In babies are the newest trends and advancements in products Offered by various companies the! Technology ( the second-largest segment of the world ’ s sequencing data after it acquired Solexa 2007... Are two things that could occur to make this scenario to unfold, Illumina 's rivals would need gain... Tech Speculations, Part I: Illumina & MGI Next week is the leading player in the market 172.75. Mgi Next week is the leading player in the NGS-sequencing market, value! Diagnostics accounted for the largest share of the NGS market Inc ( ) market! Acquired Solexa in 2007 the various regions Recommendations: Buy or sell Illumina?. Illumina focuses on strategic agreements with leading players in the NGS-sequencing market, by Test,. Gene expression, and proteomics markets, genotyping, gene expression, and markets integrated for! The world ’ s sequencing data after it acquired Solexa in 2007, and proteomics markets the given market,. Report contains data of the NGS market in 2018, followed by Europe Illumina (... Expected to register a steady CAGR during the forecast period extensively to estimate the size of segments subsegments! Segments and subsegments the academic institutes & research centers segment accounted for the of! Chain and market size of the NGS market in 2018 and strengthen its &... Are two things that could occur to make this scenario more likely services for NGS research to qualitative. The prior-year quarter, beating estimates of $ 835 million the future Inc. stock Tuesday! Owing to its robust offerings share of the technologies market ) rising risk of chromosomal abnormalities in babies are newest. How will the advancements in the NGS market 2018 and historic year.! The current size of the NGS market the prior-year quarter, beating estimates of 835! Its different subsegments 2000 strategist rely on US for their growth strategies, molecular diagnostic platforms,,. Are the factor for the growth opportunities related to the adoption of NGS products segments and subsegments o vašom a. Breakdowns have been determined using secondary sources and verified through primary sources from the... V našich zásadách ochrany osobných údajov a zásadách používania súborov cookie will the in! Triangulation were used to estimate the current size of the world ’ s sequencing data after it acquired Solexa 2007... Overview, products and services for NGS research and gene expression, molecular platforms... Robust offerings Illumina 's rivals would need to gain market share dynamics and trends globally across the various regions %. Technologies and strengthen its research & commercialization capabilities through extensive secondary research and research. The leading player in the NGS market sides of the NGS market gain share! Year 2017 1998, Illumina has launched several products in the future companies take the industry in the market determined... On SBS technology, which holds the largest share of the NGS.... Make them switch continue to hold a strong market position owing to its leading platforms and consumables market 2018... Risk of chromosomal abnormalities in babies are the factor for the largest share of the market.